FDA confirms dietary fiber status of inulin
The US Food and Drug Administration (FDA) recognizes inulin-type fructans derived from chicory root as dietary fiber for the new nutrition facts label. The recognition consolidates the fiber status of chicory root fiber in the US and supports further opportunities for healthy food applications in the US.
The announcement follows a joint citizen petition requesting the addition of chicory root fiber to the list of dietary fibers accepted in the US as well as a comprehensive response to the FDAs scientific review of inulin-type-fructans and data request. In 2015, the FDA issued new Nutrition Facts labeling regulations for food and supplements to be implemented by January 1st, 2020. In the new regulation, dietary fibers are defined as naturally occurring fibers that are intrinsic and intact in plants, or as isolated or synthetic fibers that have demonstrated a beneficial physiological effect.
Carl Volz, President Sensus America, states: “inulin/oligofructose has been clearly shown to support physiological health benefits as assessed by the FDA’s strict criteria”. He adds: “The FDA’s inclusion of chicory root fiber as a dietary fiber in its new food labeling regulations allows our customers to continue marketing their products as sources of dietary fiber and to continue to use chicory root fiber as a tool to reduce calories and added sugar.”
CHIC project aims to develop chicory varieties that can be used to produce a dietary fiber with enhanced prebiotic effects to promote gut health.
About CHIC Project
CHIC is the Chicory Innovation Consortium. Its objective is to implement New Plant Breeding Techniques (NPBTs) in chicory in order to establish it as a multipurpose crop for the production of health-related products with clear benefits for consumers and to develop co-innovation pathways with stakeholders for game-changing technologies, such as NPBTs. CHIC will develop four different NPBTs. They will be used to steer bioprocesses in chicory and mobilize its under-explored potential to produce immunomodulatory prebiotics and medicinal terpenes. The conceptually different NPBTs will be assessed with respect to technological potential, risks, regulatory framework, and their socio-economic impacts. This will be done in close consultation with a Stakeholder Advisory Group (SAG) composed of relevant stakeholders in industry and society. For more information, visit our website at chicproject.eu/